Tamborini E - Search Results

1

T315I-mutated Bcr-Abl in chronic myeloid leukemia and imatinib: insights from a computational study.

Pricl S, Fermeglia M, Ferrone M, Tamborini E. Pricl S, et al. Among authors: tamborini e. Mol Cancer Ther. 2005 Aug;4(8):1167-74. doi: 10.1158/1535-7163.MCT-05-0101. Mol Cancer Ther. 2005. PMID: 16093432

2

Functional analysis and molecular modeling show a preserved wild-type activity of p53(C238Y).

Ferrone M, Perrone F, Tamborini E, Paneni MS, Fermeglia M, Suardi S, Pastore E, Delia D, Pierotti MA, Pricl S, Pilotti S. Ferrone M, et al. Among authors: tamborini e. Mol Cancer Ther. 2006 Jun;5(6):1467-73. doi: 10.1158/1535-7163.MCT-06-0012. Mol Cancer Ther. 2006. PMID: 16818505

3

Activate and resist: L576P-KIT in GIST.

Conca E, Negri T, Gronchi A, Fumagalli E, Tamborini E, Pavan GM, Fermeglia M, Pierotti MA, Pricl S, Pilotti S. Conca E, et al. Among authors: tamborini e. Mol Cancer Ther. 2009 Sep;8(9):2491-5. doi: 10.1158/1535-7163.MCT-09-0662. Epub 2009 Sep 1. Mol Cancer Ther. 2009. PMID: 19723893

4

T670X KIT mutations in gastrointestinal stromal tumors: making sense of missense.

Negri T, Pavan GM, Virdis E, Greco A, Fermeglia M, Sandri M, Pricl S, Pierotti MA, Pilotti S, Tamborini E. Negri T, et al. Among authors: tamborini e. J Natl Cancer Inst. 2009 Feb 4;101(3):194-204. doi: 10.1093/jnci/djn477. Epub 2009 Jan 27. J Natl Cancer Inst. 2009. PMID: 19176456

5

Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib.

Conca E, Miranda C, Dal Col V, Fumagalli E, Pelosi G, Mazzoni M, Fermeglia M, Laurini E, Pierotti MA, Pilotti S, Greco A, Pricl S, Tamborini E. Conca E, et al. Among authors: tamborini e. Mol Oncol. 2013 Aug;7(4):756-62. doi: 10.1016/j.molonc.2013.02.019. Epub 2013 Mar 21. Mol Oncol. 2013. PMID: 23567324 Free PMC article.

6

Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients.

Tamborini E, Pricl S, Negri T, Lagonigro MS, Miselli F, Greco A, Gronchi A, Casali PG, Ferrone M, Fermeglia M, Carbone A, Pierotti MA, Pilotti S. Tamborini E, et al. Oncogene. 2006 Oct 5;25(45):6140-6. doi: 10.1038/sj.onc.1209639. Epub 2006 Jun 5. Oncogene. 2006. PMID: 16751810

7

Targeted therapies: the rare cancer paradigm.

Pierotti MA, Negri T, Tamborini E, Perrone F, Pricl S, Pilotti S. Pierotti MA, et al. Among authors: tamborini e. Mol Oncol. 2010 Feb;4(1):19-37. doi: 10.1016/j.molonc.2009.10.003. Epub 2009 Oct 28. Mol Oncol. 2010. PMID: 19913465 Free PMC article. Review.

8

Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling study.

Dileo P, Pricl S, Tamborini E, Negri T, Stacchiotti S, Gronchi A, Posocco P, Laurini E, Coco P, Fumagalli E, Casali PG, Pilotti S. Dileo P, et al. Among authors: tamborini e. Int J Cancer. 2011 Feb 15;128(4):983-90. doi: 10.1002/ijc.25418. Int J Cancer. 2011. PMID: 20473908

9

Re: Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis.

Tamborini E, Negri T, Miselli F, Lagonigro MS, Pricl S, Pilotti S. Tamborini E, et al. J Natl Cancer Inst. 2006 Nov 1;98(21):1583-4. doi: 10.1093/jnci/djj417. J Natl Cancer Inst. 2006. PMID: 17077361 No abstract available.

10

KIT/Val654 Ala receptor detected in one imatinib-resistant GIST patient.

Tamborini E, Gabanti E, Lagonigro MS, Negri T, Pilotti S, Pierotti MA, Pricl S. Tamborini E, et al. Cancer Res. 2005 Feb 1;65(3):1115; author reply 1115. Cancer Res. 2005. PMID: 15705916 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters